Pharming Group (NasdaqGM:PHAR) Q1 2026 Earnings call May 07, 2026 07:30 AM ET Company Participants Anurag Relan - Chief Medical Officer Fabrice Chouraqui - CEO Kenneth Lynard - CFO Leverne Marsh - Chief Commercial Officer Conference Call Participants Benjamin Jackson - Analyst Jeff Jones - Analyst Natalia Webster - Analyst Simon Scholes - Analyst Suzanne Van Voorthuizen - Analyst Whitney Ijem - Analyst None - Analyst Operator Good day, and thank you for standing by. Welcome to the Pharming Group N.V. first ...